Web Analytics

3 Latest Announced Rounds

  • $10,000,000
    Seed

    1 Investors

    Data Infrastructure and Analytics
    Aug 22nd, 2025
  • $4,873,008
    Seed

    4 Investors

    Residential Building Construction
    Aug 22nd, 2025
  • $20,000,000
    Series A

    2 Investors

    Medical Equipment Manufacturing
    Aug 22nd, 2025
$901.54M Raised in 52 Funding Rounds in the past 7 Days - View All

Funding Round Profile

OrsoBio

start up
United States - Palo Alto, CA
  • 08/11/2023
  • Series A
  • $60,000,000

OrsoBio, Inc. is a privately held, clinical-stage biopharmaceutical company dedicated to developing therapies to treat severe metabolic disorders, including type 2 diabetes, severe dyslipidemias, lipodystrophies, and nonalcoholic steatohepatitis. OrsoBio currently has four programs in clinical and preclinical development with first-in-class compounds that address central pathways in energy metabolism.


Related People

G. Mani SubramanianFounder

G. Mani Subramanian United States - San Francisco Bay Area

N/A